Tassal Group Limited Overview
Tassal is Australia's largest vertically integrated aquaculture-led seafood business and was, until 2026, Tasmania's largest Atlantic salmon producer by volume. It runs freshwater hatcheries, marine farms, processing plants and branded sales channels for Tasmanian Atlantic salmon. It has diversified into Queensland black tiger prawns under the Tropic Co brand, ocean-farmed barramundi at Cone Bay in Western Australia (acquired 2023), and seafood wholesaling and retail through De Costi Seafoods in Sydney. After three decades as a home-grown company and 19 years on the ASX, Tassal was acquired by Canada's Cooke Inc. in November 2022 for about A$1.7bn in enterprise value. That deal made it Cooke's first and largest-ever investment, and Cooke's Australian platform. Tassal's competitive franchise rests on scarce marine lease access, scale in domestic retail, and its brand. The operating environment since 2025 has been defined by warming waters, endemic Piscirickettsia salmonis disease, antibiotic controversy, Macquarie Harbour environmental politics, and the loss of its top-producer ranking to JBS-owned Huon Aquaculture.
Company's own description
In its final ASX-era materials (SID announcement, August 2022; Annual Report 2022), Tassal described itself as a vertically integrated salmon and prawn grower, and a salmon, prawn and seafood processor, seller and marketer. In the Cooke merger release it was described as Australia's largest vertically integrated seafood producer and "blue agri-tech" business.
Its stated purpose after the acquisition, used in the 2023 barramundi announcement, is "Sustainably Feeding Tomorrow". Earlier corporate messaging focused on growing domestic per-capita consumption of salmon and prawns through brand building.
Independent characterisation
Tassal is a biological-asset-intensive protein producer. It controls nearly the whole value chain:
-
Genetics and smolt. Access to the Tasmanian industry selective-breeding programme run by SALTAS; company hatcheries, including the Rookwood nursery, where smolt spend 8–12 months before sea transfer. FY2019 plans included a multi-purpose recirculating aquaculture system (RAS) smolt facility budgeted at about A$46m.
-
Grow-out. Marine leases in south-east Tasmania (Huon/D'Entrecasteaux Channel, Bruny Island and Great Taylors Bay, Tasman Peninsula including Long Bay, Storm Bay, Okehampton Bay/Mercury Passage) and the west coast (Macquarie Harbour). The ABC reported in August 2026 that Tassal holds 18 marine farm environmental licences, four freshwater hatcheries and four processing sites in Tasmania.
-
Processing. Fresh whole fish, fillets and portions, smoked and value-added products.
-
Marketing and distribution. Branded retail (major supermarkets), foodservice ("out-of-home"), wholesale, export (especially Asia), and the De Costi Seafoods retail/wholesale business in NSW.
Revenue model. Almost entirely product sales of farmed and traded seafood. There is no material service, subscription or licensing revenue. Statutory results also carry fair-value adjustments on biological assets (AASB 141). This is why Tassal historically reported both "statutory" and "operating" (excluding fair-value and one-off items) earnings.
Customer types.
-
Australian supermarket chains (retail)
-
Foodservice and restaurants
-
Seafood wholesalers
-
De Costi retail customers
-
Export customers (Asia-focused in FY2022). Exports were 20.3% of total sales in 1H FY2020 (company 1H20 results, reported by The Motley Fool)
End markets. Australian retail seafood (dominant), Australian foodservice, export salmon (opportunistic, price-driven), and the domestic premium prawn and barramundi markets.
Strategy
Final ASX-era strategy (Annual Report 2022 themes, paraphrased)
-
Tassal described itself as having reached scale after a heavy investment cycle, freeing it to emphasise cash flow and shareholder returns.
-
With incremental biomass funding no longer needed, growth would come from sales mix, cost optimisation, product innovation and brand building.
-
Leverage unique assets: lease positions, hatcheries, processing, and the De Costi channel.
-
Grow domestic per-capita consumption of salmon and prawns.
-
Transfer salmon know-how to prawns.
-
Targeted dividend payout of at least 50% of operating NPAT (1H22 release).
-
Responsible Business Blueprint and ambition to be one of the world's most transparent and sustainable protein producers.
Cooke-era stated intentions (Aug–Nov 2022)
Cooke's stated plans at acquisition were to:
-
Keep existing operations management in place.
-
Make strategic investments in engineering, science and technology.
-
Expand Tassal's sales reach through Cooke's global distribution network.
-
Prioritise collaboration with other producers and regulators on continuous environmental improvement.
Initiatives in the last 24 months (Oct 2024–Oct 2026)
| Initiative | Date | Detail | Source |
|---|---|---|---|
| Florfenicol medicated-feed treatments under APVMA emergency permit | Nov 2025–Mar 2026 | Industry used florfenicol 13 times between early Nov 2025 and late Jan 2026. Tassal treated GTB2 from 24 Jan to 2 Feb 2026 and started treatments at five leases around 22 Feb 2026 | Fish Farming Expert; Tasmanian Greens; Tasmanian Country |
| Application for florfenicol at Okehampton Bay | Early 2026 | Noted in a Legislative Council motion | Rosemary Armitage MLC, 24 Mar 2026 |
| Industry campaign "Tasmanians Depend on Salmon" (via Salmon Tasmania) | Apr 2026 | Advertising campaign built on testimonials from workers in businesses that depend on the industry | ABC News, 22 Apr 2026 |
| Long Bay lease continuation | Aug 2026 | Two-year EPA extension | ABC News |
| At-sea oxytetracycline injections | Oct 2026 | Each fish is anaesthetised, injected, monitored and returned to its pen. Tassal says this uses a fraction of the medicine needed for medicated feed and that environmental exposure is expected to be low, localised and short-lived | ABC; Pulse Tasmania; LAFM |
| Climate-risk disclosure | 2,026 | Tassal's climate report estimates 1°C of warming would raise mortality from 15 to 18.5 fish per 100 | UTS ISF report via Mirage News / Port News, Oct 2026 |
Medium-term targets
Not publicly disclosed since delisting. The last public targets were:
-
A sustainable salmon harvest of about 40,000 HOG t from existing leases (1H22).
-
A payout ratio of at least 50% of operating NPAT. This is now irrelevant under private ownership.
Products & Services
Salmon (Tasmanian Atlantic salmon)
| Brand / line | Description | Target customer | Notes |
|---|---|---|---|
| Tassal (master brand) | Fresh Tasmanian Atlantic salmon: whole fish, fillets, portions, skin-on/skinless retail packs | Supermarket shoppers, foodservice | Core brand. FY2021 strategy focused on "Tassal branded retail" |
| Tassal Superior Gold / Tassal Chef Selection Superior Gold | Premium salmon line, reportedly relaunched as "Tassal Chef Selection Superior Gold" | Premium retail and foodservice | Relaunch per IBISWorld enterprise profile (date not disclosed) |
| Tasmanian Smokehouse | Smoked salmon products (hot- and cold-smoked) | Retail deli and gourmet | Listed among Tassal brands in Fish Farmer, Nov 2022 |
| Value-added and ready-to-cook salmon | Marinated portions and meal-solution formats | Convenience retail | Specific SKUs and launch dates not publicly disclosed |
| Export salmon | Whole fish and fillets for Asian markets | Importers and distributors | Export share was 20.3% of sales in 1H FY2020 |
Key specifications. Average harvest size was 4.52 kg HOG in FY2020, versus 4.39 kg in FY2019 (Kalkine, citing company reports). Larger fish improve processing yields and domestic pricing. Sustainable harvest from existing leases was described as about 40,000 HOG tonnes per year in 1H FY2022.
Prawns
| Brand / line | Description | Target customer | Notes |
|---|---|---|---|
| Tropic Co – The Aussie Prawn | Australian black tiger prawns (Penaeus monodon): cooked, raw, whole and peeled formats | Retail and foodservice | Grown at Queensland and northern NSW pond farms. Capacity about 5,500 t from two hatcheries, three pond farms and processing facilities (Fish Farmer, Nov 2022) |
Sites referenced in company disclosures include Proserpine and Mission Beach (Queensland), Yamba (NSW) and Billy Creek (acquired Nov 2020). Tassal's selective breeding programme for prawns was initiated by 2019.
Barramundi
| Brand / line | Description | Target customer | Notes |
|---|---|---|---|
| Tassal Barramundi (ocean-farmed, Western Australia) | Ocean-grown barramundi from Cone Bay, Kimberley region | Retail | MPA acquisition completed Aug 2023. About 1,600 t/yr. Tassal-branded barramundi scheduled to reach market in Nov 2023 |
Seafood distribution and retail
| Brand / business | Description | Target customer | Notes |
|---|---|---|---|
| De Costi Seafoods | Seafood processor, wholesaler and retailer in Sydney (Lidcombe, NSW); distributes Tassal salmon and prawns plus third-party seafood | Retail, wholesale, foodservice | Acquisition announced 1 Jul 2015 |
| Cooke Seafood (Australia) | Cooke group seafood products marketed in Australia | Retail and foodservice | Listed as a Tassal-operated brand by IBISWorld; scope not publicly disclosed |
Pricing model. Tassal sells on negotiated retail supply agreements and spot or contract wholesale and export pricing. Domestic retailers accepted cost-driven price increases in FY2022 (company commentary reported by SalmonBusiness). Specific price lists are not publicly disclosed.
Financial Narrative
Important: Tassal has not published financial statements since FY2022. FY2023–FY2026 figures are not publicly disclosed.
Income statement
Sources and derivations:
-
FY2022: Annual Report 2022 and FY22 results release (16 Aug 2022). Statutory EBITDA +35.7%; statutory NPAT +59.9%; operating EBITDA +25.3%; operating NPAT +31.9%.
-
FY2021 derived from FY2022 growth rates: statutory EBITDA 162.6/1.357; statutory NPAT 55.4/1.599; operating EBITDA 174.5/1.253; operating NPAT 63.7/1.319.
-
FY2020: Annual Report 2020 and Kalkine. Operating EBITDA A$138.55m (+23.4%); statutory EBITDA A$145.61m (+26.7%); statutory NPAT A$69.11m (+18.3%); operating NPAT A$64.17m (+13.3%).
-
FY2019: Annual Report 2019 and Kalkine. Revenue A$560.8m; operating NPAT A$56.6m (+12.5%); statutory NPAT about A$58.4m. FY2019 EBITDA figures are derived from FY2020 growth rates. Operating EBIT of A$88.55m (+15.4%) per SalmonBusiness.
-
FY2018: revenue from all sources per Annual Report 2019 comparative; operating NPAT derived (56.6/1.125).
Not reported: Gross profit and pre-tax income were not reported in a form verifiable from the sources reviewed (Tassal reported EBITDA-centric metrics). FY2022 had an 8c interim, and the scheme price assumed no FY2022 final dividend.
Margins (%)
Margins are calculated from the table above. Kalkine separately cites an FY2020 EBITDA margin of 22.6%, presumably on a different revenue base.
Revenue CAGR. FY2018–FY2022 compound annual growth was about 12.9% (484.5 to 788.7 over four years). Kalkine reported a 2016–2020 revenue CAGR of 6.76% and a 2015–2019 CAGR of about 16%.
Cash flow
Sources: FY2022 from Annual Report 2022 (OCF +127.8%; FCF A$95.4m vs A$29.5m; FCF after investing A$62.7m inflow vs A$44.6m outflow). FY2021 OCF derived (139.03/2.278). FY2019 A$89.9m (+104.9%) and FY2020 A$49.85m (−44.5%) per Kalkine and Food & Drink Business. FY2018 derived.
Capex. Not separately verified by year. The Annual Report 2022 states that capital investment from FY2018 to FY2021 totalled about A$420m. Guidance for FY2021 total capex was about A$125.1m (Kalkine).
Balance sheet
Aggregator claim: roic.ai states Tassal secured an A$497m sustainability-linked loan in 2022.
Ratios
FY2019 operating ROA of 10.3% is per Kalkine; the 1H19 investor presentation shows 10.6%, excluding prawns. Net debt/EBITDA is calculated as 333.3/174.5. The 10.0x EV/EBITDA figure is per the SID announcement.
ROE, ROIC, current ratio, interest coverage, asset turnover and the cash conversion cycle are not publicly disclosed or verified. The company itself noted that operating ROA and ROIC fell in FY2020 because of heavy strategic capital investment.
Commentary on trends and inflections
FY2018–FY2019: volume-led growth. Revenue grew 15.7% and salmon revenue 19.9%. Salmon harvest rose 7.0% to 33,036 HOG t, and sales volumes rose 10.3% to 33,856 t (SalmonBusiness, FY19 results).
FY2020: margin over volume. Revenue was flat (+0.3%). Operating EBITDA nonetheless rose 23.4% as EBITDA per kg climbed 14%, helped by larger fish and a deliberate shift toward domestic sales. Cash conversion collapsed (OCF −44.5%) because Tassal deliberately built salmon and prawn biomass and inventory.
FY2021: COVID trough. Export prices fell sharply and Tassal had to fund export freight (about €6.1m of extra freight cost in 1H21). Statutory NPAT roughly halved to about A$34.6m. Operating EBITDA held about flat, which shows the biomass build continued.
FY2022: step change. Revenue jumped 32.8% to A$788.7m. Drivers were salmon volume (about 40,000 t), historically high global salmon prices, domestic retail price pass-through, Asian export leverage, and prawn harvests roughly doubling. The investment phase ended (about A$420m invested over FY2018–FY2021) and free cash flow turned decisively positive. That inflection is what Cooke paid for, at about 10x FY2022 EBITDA.
Post-FY2022. Not publicly disclosed. The operating evidence points to a harder environment from FY2025: flat Tasmanian volumes (33,523 t in FY2025 and 33,388 t in FY2026, well below the roughly 40,000 t capacity cited in 2022), mass mortalities and antibiotic constraints. It would be unsafe to infer financial figures.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment
| Segment | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Salmon revenue (AUD Mn) | 395.47 | 474.03 | — | 470.54 | 610.92 |
Prawn revenue (AUD Mn) | — | 9.1 | 41.4 | — | — |
Total group revenue, all sources (AUD Mn) | 484.54 | 560.79 | 562.54 | 593.9 | 788.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansResults by Segment and Unit Economics (AUD/kg)
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Salmon EBITDA (AUD Mn) | — | — | 120.03 | 146.59 |
Salmon EBITDA per kg (AUD) | 3.16 | 3.60 | 3.20 | 3.40 |
Salmon revenue growth YoY (%) | 19.9 | — | — | 29.8 |
Salmon EBITDA growth YoY (%) | 14.5 | — | — | 22.1 |
Revenue by Segment (%)
| Metric | FY2018 | FY2019 | FY2021 | FY2022 |
|---|---|---|---|---|
Salmon share of group revenue (%) | 81.6 | 84.5 | 79.2 | 77.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%)
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Revenue, all sources (AUD Mn) | 484.54 | 560.79 | 562.54 | 593.9 | 788.7 |
Revenue growth YoY (%) | — | 15.7 | 0.3 | 5.6 | 32.8 |
Statutory EBITDA (AUD Mn) | — | 114.9 | 145.61 | 119.8 | 162.6 |
Operating EBITDA (AUD Mn) | — | 112.3 | 138.55 | 139.3 | 174.5 |
Operating EBIT (AUD Mn) | — | 88.55 | — | — | — |
Statutory NPAT (AUD Mn) | — | 58.4 | 69.11 | 34.6 | 55.35 |
Operating NPAT (AUD Mn) | 50.3 | 56.6 | 64.17 | 48.3 | 63.69 |
Dividends per share (A$ cents) | 16 | 18 | 18 | — | — |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
Statutory EBITDA margin (%) | 20.5 | 25.9 | 20.2 | 20.6 |
Operating EBITDA margin (%) | 20.0 | 24.6 | 23.5 | 22.1 |
Statutory net margin (%) | 10.4 | 12.3 | 5.8 | 7.0 |
Operating net margin (%) | 10.1 | 11.4 | 8.1 | 8.1 |
Cash Flow
| Metric | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | 43.9 | 89.9 | 49.85 | 61.0 | 139.03 |
Free cash flow, OCF less maintenance capex (AUD Mn) | — | — | — | 29.5 | 95.4 |
Free cash flow after investing activities (AUD Mn) | — | — | — | -44.6 | 62.7 |
Key Financials
| Metric | FY2022 |
|---|---|
Net debt at 30 June (AUD Mn) | 333.3 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2019 | FY2022 |
|---|---|---|
Operating ROA (%) | 10.3 | — |
Net debt / operating EBITDA (x) | — | 1.9 |
Takeover EV / FY2022 EBITDA (x) | — | 10.0 |
Revenue by Region (%)
| Metric | FY2019 | FY2020 |
|---|---|---|
Domestic salmon sales volume (HOG t) | 26,860 | 28,259 |
Export share of total sales, 1H FY2020 (%) | — | 20.3 |
Valuation Snapshot
| Metric | Value | Date | Source |
|---|---|---|---|
Undisturbed share price (AUD) | 3.52 | 22 Jun 2022 | SID announcement |
Scheme consideration (A$/share) | 5.23 | Nov 2022 | ASX |
Premium to undisturbed price (%) | 49 | Aug 2022 | ASX |
Equity value at scheme (AUD Bn) | 1.1 | Aug 2022 | ASX |
Enterprise value at scheme (AUD Bn) | 1.7 | Aug 2022 | ASX |
EV / FY22 EBITDA (x) | 10.0 | Aug 2022 | ASX |
Market capitalisation (AUD Mn) | 726 | 1 Oct 2020 | Kalkine |
Market capitalisation (AUD Mn) | 777 | 19 Nov 2020 | Kalkine |
Share price after 1H20 result (AUD) | 4.50 | 12 Feb 2020 | The Motley Fool |
Per-Share Data
| Metric | FY2015 | FY2018 | FY2019 | FY2020 | FY2022 |
|---|---|---|---|---|---|
Total DPS (cents) | 14 | 16 | 18 | 18 | 8 |
Analyst Conclusions
Guidance and consensus
-
No public guidance or consensus exists because Tassal is a private subsidiary.
-
Operational indicators to watch: summer 2026–27 mortality (EPA monthly data), the new florfenicol permit decision, and FY2027 harvest volumes (NRE portal).
Bull case
-
Strong platform economics. FY2022 showed the platform can generate A$174.5m operating EBITDA and A$95.4m free cash flow once biomass and prices align. Cooke's capital and engineering could restore volumes toward 40,000 t.
-
Diversification hedge. Prawns (historically about 2.5x salmon EBITDA/kg) and barramundi reduce dependence on Tasmanian inshore salmon.
-
Political backing. Bipartisan support (the 2025 EPBC amendment and the A$18.3m oxygenation programme) lowers the risk of forced closures.
Bear case
-
Structural disease and climate risk. Endemic P. salmonis combined with warming seas makes disease a recurring cost. Tassal's own data imply roughly 23% more mortality per 1°C of warming.
-
Shrinking treatment toolkit. The florfenicol suspension and the injection-only alternative are labour-intensive, while community and export-industry opposition is intensifying.
-
Competitive and regulatory squeeze. Huon has overtaken Tassal, and growing pressure for offshore relocation implies heavy capex with uncertain returns.
Catalysts and monitorables (next 12 months)
-
Summer 2026–27 marine heatwave impact and mortality figures (EPA monthly releases).
-
APVMA ruling on the new florfenicol permit application by Salmon Tasmania.
-
Outcome of the Animals Australia complaint.
-
Legal challenges over Macquarie Harbour and Maugean skate monitoring.
-
FY2027 NRE production data (Tassal vs Huon).
-
Any Cooke disclosure on Australian investment (offshore pens, RAS), restructuring, or barramundi expansion.
-
Leadership succession after Mark Ryan's 23-year tenure.
Analyst verdict
Tassal is a high-quality but increasingly stressed asset. Its last public year, FY2022, showed what a fully invested Tasmanian salmon platform can produce when biology and prices cooperate: A$788.7m in revenue, A$174.5m operating EBITDA and a step change in free cash flow. Cooke paid a full but defensible multiple of about 10x EBITDA, a 49% premium, for scarce lease access, a dominant domestic brand position and a multi-species growth path.
Four years on, the investment case looks different. The core salmon business appears stuck at about 33,400 tonnes. That is well below the roughly 40,000 tonnes once described as sustainable, and Tassal has ceded volume leadership to JBS-owned Huon. The defining variable is no longer market price but biology. Piscirickettsia salmonis is now endemic in south-east waters, the 2025 industry mortality reached 20,133 tonnes, and the regulator removed Tassal's preferred antibiotic in March 2026 after residues reached wild export fisheries. Tassal's own climate disclosure concedes materially higher mortality with each degree of warming, and summer 2026–27 begins with seas already 2–3°C above normal.
Mitigants are real. Political support at both levels of government has neutralised the Macquarie Harbour threat for now. Prawns and barramundi provide margin diversification, and Cooke's balance sheet and global engineering capabilities allow investment through the cycle in a way a standalone ASX company could not.
On balance, Tassal remains a strategic franchise with sound long-run economics, but its near-term earnings power is likely impaired relative to FY2022. The direction of travel will depend on whether Cooke funds a decisive shift toward higher-energy, offshore or RAS-supported production. Absent such a shift, recurring summer mortality, regulatory tightening and social-licence erosion are likely to cap value. Because no financial statements have been published since FY2022, any valuation view should be treated as provisional until Cooke or Tassal discloses current figures.
Primary and secondary sources referenced:
-
Tassal ASX announcements: Annual Reports 2019, 2020 and 2022; 1H FY22 results; SID announcement (16 Aug 2022); scheme implementation (21 Nov 2022); Goldman Sachs Emerging Leaders Conference presentation (Apr 2019)
-
Cooke Inc. press releases (Aug 2022, Nov 2022, Aug 2023)
-
APVMA statements (Feb–Mar 2026); Tasmanian NRE florfenicol page
-
ABC News; Pulse Tasmania; SalmonBusiness; Fish Farmer; Fish Farming Expert; Undercurrent News; SeafoodSource
-
Food & Drink Business; Business News Australia; The Examiner / Stock & Land; Canberra Times; Tasmanian Times; Tasmanian Country; Port News
-
Mirage News (UTS ISF report); Business & Human Rights Resource Centre; Tasmanian Greens media releases; Rosemary Armitage MLC motion
-
Aggregators: Kalkine; IBISWorld; Simply Wall St; MarketScreener; roic.ai; FAIRR; Wikipedia
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background | Source |
|---|---|---|---|---|
Mark Andrew Ryan | Managing Director & CEO, Tassal; Managing Director, Aquaculture Australia Holdco Pty Ltd | CEO since Nov 2003 (about 23 years) | B.Com, University of Tasmania (1994); Chartered Accountant; former partner at KordaMentha; former Chair, Macquarie Point Development Corporation; former director of Bellamy's Australia and the AFL; director roles include SALTAS, Tasmanian Salmonid Growers Association, Seafood Industry Australia, AFL Tasmania and the Institute for Marine & Antarctic Studies | MarketScreener; Simply Wall St; IBISWorld; Annual Report 2022 |
Glenn Cooke | Director, Tassal (from 21 Nov 2022); CEO, Cooke Inc. | Since Nov 2022 | Co-founder and CEO of the Cooke family of companies | ASX announcement, 21 Nov 2022 |
James Trask | Director, Tassal (from 21 Nov 2022) | Since Nov 2022 | Cooke group nominee; further details not publicly disclosed | ASX announcement, 21 Nov 2022 |
Mark Asman | Head of Aquaculture (as listed in the 2020 and 2022 Annual Reports) | Long-serving | — | Annual Reports 2020, 2022; Undercurrent News |
Board of Directors — James Fazzino
| Name | Role | Appointed | Notes |
|---|---|---|---|
James Fazzino | Independent Chair | Director 29 May 2020; Chair 28 Oct 2021 | B.Ec (Hons), CPA |
Richard Haire | Independent Non-Executive Director | 5 Mar 2020 | B.Ec, FAICD |
Georgina Lynch | Independent Non-Executive Director | — | — |
Jackie McArthur | Independent Non-Executive Director | — | — |
Kathy Parsons | Independent Non-Executive Director | 29 Oct 2021 | B.Com, ACA |
John Watson | Non-Executive Director | — | — |
Mark Ryan | Managing Director & CEO | Nov 2003 | — |
Major Shareholders
| Holder | Stake (%) | Date / note |
|---|---|---|
Aquaculture Australia Company Pty Ltd (Cooke Inc.) | 100 | Since 21 Nov 2022 |
Cooke pre-scheme stake (excluded from scheme vote) | 10.5 | Aug 2022 |
Yarra Capital (sold just under 5% block that Cooke acquired) | — | Jun 2022 |
Competitive Landscape
Key Competitors
| Competitor | Owner | Segment overlap | Positioning vs Tassal |
|---|---|---|---|
Huon Aquaculture | JBS (Brazil), acquired 2021 for about A$425m | Tasmanian salmon | Now the largest Tasmanian producer (34,588 t in FY2026); invested in offshore "fortress pens" and Storm Bay; RSPCA certification later withdrawn |
Petuna Aquaculture | Sealord (New Zealand) | Tasmanian salmon (Macquarie Harbour, north-west) | Third producer (6,272 t in FY2026); Tassal's Macquarie Harbour JV partner |
Imported salmon (Norway and others) | Various | Domestic salmon | Price competitor when supply is short |
Mowi | Listed (Oslo) | Global salmon (export markets) | Global price-setter |
SalMar | Listed (Oslo) | Global salmon | Export competitor |
Lerøy Seafood | Listed (Oslo) | Global salmon | Export competitor |
Cermaq | Mitsubishi Corporation | Global salmon | Export competitor |
New Zealand King Salmon | Listed (NZX/ASX) | Premium salmon in Australia | Premium niche competitor |
Australian prawn farmers (e.g., Pacific Reef Fisheries, Gold Coast Marine Aquaculture) | Private | Farmed prawns | Domestic prawn rivals |
Imported prawns (Vietnam, Thailand, etc.) | Various | Prawns | Price competition |
Australian barramundi farmers (e.g., Humpty Doo Barramundi, Mainstream Aquaculture) | Private | Barramundi | Domestic rivals in the new species |
Wild-catch seafood suppliers | Various | Retail seafood protein | Substitutes |
Peer Comparison
| Producer | FY2025 | FY2026 |
|---|---|---|
Tassal (t) | 33,523 | 33,388 |
Huon Aquaculture (t) | 27,321 | 34,588 |
Petuna (t) | 7,139 | 6,272 |
Tasmania total (t) | 67,984 | 74,249 |
Tassal share (%) | 49.3 | 45.0 |
Peer Comparison FY2022
| Metric | Tassal FY2022 | Huon 1H FY2021 |
|---|---|---|
Revenue (AUD Mn) | 788.7 | 220.1 |
Revenue growth (%) | 32.8 | 24 |
Statutory NPAT (AUD Mn) | 55.35 | -95.3 |



